ENGINEERED DENDRITIC CELLS AND USES FOR THE TREATMENT OF CANCER
摘要
This invention provides the field of therapeutics. Most specifically present invention provides methods of generating in vitro engineered dendritic cells conditionally expressing interleukin-12 (IL- 12) under the control of a gene expression modulation system in the presence of activating ligand and uses for therapeutic purposes in animals including human.
申请公布号
EP2207874(A1)
申请公布日期
2010.07.21
申请号
EP20080836827
申请日期
2008.10.08
申请人
INTREXON CORPORATION;UNIVERSITY OF PITTBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION